McCormick & (MKC) Earnings Analysis
McCormick & (MKC) next reports earnings on 2026-10-06, consensus EPS 0.75 USD. Last quarter (2026-06-25) it beat with EPS 0.8 USD vs 0.692 USD est (+15.6%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 8.64.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MKC next report earnings?
| Next earnings date | 2026-10-06 |
|---|---|
| Consensus EPS estimate | 0.75 USD |
| Revenue estimate | 1.98B |
MKC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-25 | 0.8 USD | 0.692 USD | +15.6% | Beat |
| 2026-03-31 | 0.66 USD | 0.594 USD | +11.1% | Beat |
| 2026-01-22 | 0.86 USD | 0.876 USD | -1.8% | Miss |
| 2025-10-07 | 0.85 USD | 0.829 USD | +2.5% | Beat |
| 2025-01-23 | 0.8 USD | 0.77 USD | +3.9% | Beat |
| 2024-10-01 | 0.83 USD | 0.68 USD | +22.1% | Beat |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
MKC valuation and analyst view
| Trailing P/E | 8.64 |
|---|---|
| Trailing EPS | 6.049 USD |
| Price / book | 2.00 |
| Dividend yield | 3.63% |
| Market cap | 13.96B |
| Analyst consensus | Hold (11 buy / 17 hold / 2 sell) |
| Avg price target | 57.2 USD |
Related research pages
Frequently asked questions
When is McCormick & (MKC)'s next earnings date?
McCormick & is next scheduled to report on 2026-10-06, with a consensus EPS estimate of 0.75 USD and revenue estimate of 1.98B.
Did MKC beat earnings last quarter?
In its 2026-06-25 report, MKC posted EPS of 0.8 USD versus a 0.692 USD estimate — a beat of 15.6%.
What is MKC's earnings track record?
Over the last 6 reported quarters with consensus data, MKC beat estimates 5 times (83%).
What is MKC's current P/E ratio and EPS?
MKC trades at a trailing P/E of 8.64 on trailing EPS of 6.049405646359584 USD.
What do analysts rate MKC?
Analyst consensus is "Hold" across 30 ratings (0 strong buy, 11 buy, 17 hold, 2 sell, 0 strong sell). Average 12-month price target: 57.2 USD.